Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
FSD Pharma Inc
C.HUGE
Alternate Symbol(s):
HUGE
Healthcare
Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is...
focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:HUGE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 25, 2024 7:48am
New Press Release - FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated...
read article.
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:58am
Buzz on the Bullboards: A recap of recent activity and stocks in focus
After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.
read article.
(1941)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Apr 22, 2024 10:58am
Celly Nutrition Forges Strategic Distribution Partnership
https://www.newsfilecorp.com/release/206239/Celly-Nutrition-Forges-Strategic-Partnership-with-BevSource-to-Accelerate-unbuzzdTM-Distribution
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 22, 2024 8:02am
New Press Release - FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated...
read article.
(167)
•••
rad10
X
View Profile
View Bullboard History
Comment by
rad10
on Apr 18, 2024 6:37am
RE:Potential Weight Loss and Liver Health Formulations
lol - the smartest guys in the room in action...... it's amazing how retail investors get sucked into these stocks. It's as though we evolved as a species to believe
...more
(105)
•••
Bigmac4000
X
View Profile
View Bullboard History
Post by
Bigmac4000
on Apr 17, 2024 12:16pm
Potential Weight Loss and Liver Health Formulations
Maybe they can spend a few million and test Unbuzzd for Covid fighting potential while they are at it. I swear they just say things to find excuses to spend money. Get one thing to a store
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 17, 2024 8:03am
New Press Release - FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
TORONTO, ON / ACCESSWIRE / April 17, 2024/ FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, announced the...
read article.
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 15, 2024 8:15pm
InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HU
JUST IN: $HUGE InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Update on Celly Nu InvestmentFSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical
...more
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 15, 2024 8:00pm
FSD Pharma Provides Update on its Investment in Celly Nutrit
NEWS: $HUGE FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 15, 2024 8:04am
New Press Release - FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting...
read article.
(167)
•••
rad10
X
View Profile
View Bullboard History
Comment by
rad10
on Apr 10, 2024 7:44am
RE:RE:RE:Reverse split? 🤔
I guess it's quite hard work conjuring up these scenarios. Takes a lot of ingenuity and creativity.
(167)
•••
rad10
X
View Profile
View Bullboard History
Comment by
rad10
on Apr 10, 2024 7:42am
RE:RE:Reverse split? 🤔
Is AD the dude trousering 3/4 of a million in executive remuneration?
(105)
•••
Bigmac4000
X
View Profile
View Bullboard History
Comment by
Bigmac4000
on Apr 09, 2024 12:06pm
RE:Reverse split? 🤔
It's sad that your stand up comedy act is realistic to what is about to happen. What happens to our junk stock Celly-Nu when FSD goes bankrupt? Will celly still try and release the gimmick drink
...more
(86)
•••
GreatGabbo
X
View Profile
View Bullboard History
Post by
GreatGabbo
on Apr 09, 2024 7:39am
Reverse split? 🤔
It may be a good time to do a reverse split to stay on the Nasdaq. I'm thinking a good ratio would be..... 201:1 ?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 07, 2024 10:57pm
New Press Release - FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide...
read article.
(86)
•••
GreatGabbo
X
View Profile
View Bullboard History
Post by
GreatGabbo
on Apr 03, 2024 9:41am
FSD 💕
This company cares about shareholders
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth